A Repurposed Drug Could Offer Hope after Many Alzheimer's Trial Failures
An experimental drug for hepatitis D triggers a cellular waste disposal system to rid mice brains of the tau protein, a major culprit in neurodegenerative disease
Biogen Halts Studies of Closely Watched Alzheimer’s Drug, a Blow to Hopes for New Treatment
Trial failure raises doubts about amyloid as a target for drug development
An Hour of Light and Sound a Day Might Keep Alzheimer’s at Bay
Playing a flashing white light and a trilling sound reversed signs of Alzheimer’s in mice. Researchers are now trying it in humans
The Creativity of ADHD
More insights on a positive side of a “disorder”
For Alzheimer’s Sufferers, Brain Inflammation Ignites a Neuron-Killing “Forest Fire”
And it could also be the kindling sparking Parkinson’s and other neurodegenerative maladies
Untangling the Ties between Autism and Obsessive-Compulsive Disorder
Autism and OCD frequently accompany each other; scientists are studying both to understand how they differ
Gene in Infamous Experiment on Embryos Points to New Stroke Treatment
Biology at the center of last year’s contentious gene-edited twins result may hold other benefits for brain injury
Better Biomarkers Could Help Us Treat Alzheimer’s
We need better molecular biomarkers to create targeted drugs
Genetic Tests for Autism Can Sometimes Change Lives
The assays don't always yield results, but the information they offer can, at times, alter the course of treatment or prevention
Why Rocking to Sleep Is a Matchless Sedative—and Elixir
Back-and-forth motions may tweak the sensory organs that control our balance and spatial orientation
A New Way to Help Manage Parkinson's
A broader range of treatments for this disorder offers patients a more personalized approach
Alzheimer’s Attack on the Brain May Vary with Race
A new study finds African-Americans with dementia have less buildup of certain toxic proteins in their brains than do whites